In support of this notion, our current study reveals that IGFBP7 potently suppresses the growth of ATC and FTC cell-derived tumors and inhibits both phosphorylation-mediated activation and kinase activity of AKT. Here, IGFBP7 is linked to thyroid cancer, nonmedullary, 2.